Rheumatoid Arthritis Trial, Recruiting NCT02748408 Sponsor: Medacta International SA Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT02748408
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a severely painful or disabling hip joint caused by osteoarthritis, injury-related arthritis, a hip condition present from development (developmental dysplasia), or bone tissue death in the hip (avascular necrosis of the femoral head).
  • People who are between 18 and 75 years old at the time of their surgery.
  • People who are already scheduled to have their first total hip replacement.

Who may not be able to join:

  • People who have an active infection.
  • People who are pregnant.
  • People who have a mental illness that may affect their ability to give informed consent, accurately report how they are feeling, or attend follow-up appointments over a 10-year period.
  • People whose hip anatomy is severely distorted, as determined by the surgeon.
  • People who have a bone-softening condition (osteomalacia) that makes a non-cemented implant unsuitable.
  • People who have active rheumatoid arthritis.
  • People who have osteoporosis (weakened or brittle bones).
  • People who have a metabolic disorder that affects bone formation and makes a non-cemented implant unsuitable (confirm with trial site).
  • People who have muscle wasting or a neuromuscular disease.
  • People who have a known allergy to the implant materials.
  • People who are unable or unwilling to give informed consent to participate in the study.
  • People whose recovery and ability to move independently would likely be affected by other existing medical problems.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0041 91 6966060

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medacta International SA
Registry
ClinicalTrials.gov
Start date
1 July 2015
Est. completion
1 July 2032

Where this trial is recruiting

🇦🇹 Austria 🇮🇹 Italy 🇨🇭 Switzerland 🇬🇧 United Kingdom

Primary endpoints

survivorship of the Medacta SMS femoral stem

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov